Abiraterone Acetate Tablet, Film Coated
Product Images NDC 71921-177

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Abiraterone Acetate (NDC 71921-177). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Florida Pharmaceutical Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bottle Label (Abiraterone Acetate Tablets Usp 500 mg Label)

Bottle Label (Abiraterone Acetate Tablets Usp 500 mg Label)
Abiraterone acetate is a medication provided in the form of film-coated tablets that contains 500 mg of the active ingredient in each tablet. The recommended dosage for abiraterone acetate can be found in the prescribing information. Store the tablets at room temperature between 20°C to 25°C, and maintain temperatures between 15°C and 30°C. Keep the product out of the reach of children and swallow the tablets whole, without crushing or chewing them. This medication is manufactured in India and distributed in the United States by Florida Pharmaceutical Products LLC. It is only available with a prescription.*
FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
The text provides a survival rate graph comparing the effects of Abiraterone Acetate Tablets and Placebo over time. Abiraterone Acetate Tablets demonstrate a higher survival rate than Placebo. However, the graph's title, additional details on its parameters, and its context are not available.*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
This appears to be a graph depicting the results of a study involving Abiraterone Acetate tablets and a placebo over the course of several months post-randomization. The y-axis contains various numeric values while the x-axis denotes the time in months. The graph may be indicating the effectiveness of the medication.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
This document seems to be a table with some information on Abiraterone Acetate tablets and the placebo. However, it is not clear what the numbers mean and how to interpret them without further context.*
FDA Label Image

Figure 4 (Figure 4)

Figure 4 (Figure 4)
This is a table showing the number of patients for whom Abiraterone Acetate was administered in a clinical trial over a period of 72 months with column headers "Subjects at risk" and "Months from Randomization". The table contains information for patients who received a placebo as well. However, no further information about the trial is given, and hence it is difficult to analyze the results.*
FDA Label Image

Structure (Structure)

Structure (Structure)
FDA Label Image

F8c59784 D6d5 285c E053 6294a90a4f4b

F8c59784 D6d5 285c E053 6294a90a4f4b

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.